Biotronik Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System

Singapore - English - HSA (Health Sciences Authority)

Buy It Now

Available from:
BIOTRONIK ASIA PACIFIC PTE. LTD.
Class:
Class D (contains therapeutic product or medicinal product)
Manufactured by:
Biotronik AG
Therapeutic area:
Cardiovascular
Therapeutic indications:
is indicated for improving luminal diameter in the treatment of de novo native coronary artery lesions in patients with symptomatic coronary artery disease. The reference vessel diameter should closely match the scaffold nominal diameter. The treated lesion length should be less than the nominal scaffold length.
Product summary:
Device System Info:[Sterile Medical Device], sterile; Models: Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412526, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412529, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412527, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412530, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412528, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412531
Authorization number:
DE0502058
Authorization date:
2018-08-27

Search alerts related to this product

Share this information